Marlowe (LON:MRL) Shares Up 1.2% – Time to Buy?

Marlowe plc (LON:MRL) shares shot up 1.2% during mid-day trading on Friday . The company traded as high as GBX 330 ($4.14) and last traded at GBX 328 ($4.11). 141,426 shares traded hands during trading, a decline of 77% from the average session volume of 606,029 shares. The stock had previously closed at GBX 324 ($4.06).

Analyst Ratings Changes

Several brokerages have recently weighed in on MRL. Royal Bank of Canada restated an “outperform” rating and issued a GBX 690 ($8.65) target price on shares of Marlowe in a research note on Thursday, August 1st. Berenberg Bank reaffirmed a “buy” rating and set a GBX 710 ($8.90) target price on shares of Marlowe in a research report on Wednesday, August 21st.

Marlowe Stock Performance

The company has a debt-to-equity ratio of 58.99, a quick ratio of 0.80 and a current ratio of 1.24. The company has a market capitalization of £287.69 million, a PE ratio of -2,342.86 and a beta of 0.44. The company has a 50 day moving average price of GBX 357.65 and a 200 day moving average price of GBX 434.09.

Insider Activity at Marlowe

In other news, insider Peter M. R. Gaze purchased 15,000 shares of the firm’s stock in a transaction that occurred on Friday, September 27th. The stock was acquired at an average cost of GBX 309 ($3.87) per share, for a total transaction of £46,350 ($58,104.55). 25.30% of the stock is currently owned by corporate insiders.

Marlowe Company Profile

Marlowe plc provides compliance services and software in the United Kingdom. The company operates in two segments, Governance, Risk and Compliance; and Testing, and Inspection and Certification. It offers health and safety consultancy, risk and audit assessments, environmental, contractor management, and training services; and health and safety support services.